Global Bacterial Vaccines Market, By Type (Live Attenuated Vaccines, Inactivated/Killed Vaccines, Subunit/Conjugate, Toxoid Vaccines/Inactivated Toxin, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Bacterial Vaccines Market Analysis and Size
The global bacterial vaccines market is expected to witness significant growth during the forecast period. Growing cases of measles, influenza and bacterial infection drives the bacterial vaccines market. However, continuous clinical studies to treat bacterial infection and procurement of vaccine by the WHO, UNICEF and other government authorities to treat severe bacterial infection will boost up the bacterial vaccines market. In addition to this, advances in the treatments and the presence of well-established healthcare facilities are some of the major impacting factors for the demand of bacterial vaccines market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global bacterial vaccines market in the forecast period 2022-2029. The expected CAGR of global bacterial vaccines market is tend to be around 8.20% in the mentioned forecast period. The market was valued at USD 19.68 billion in 2021, and it would grow upto USD 36.97 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
A Bacterial vaccine is a vaccine to suspend the killed or attenuated bacteria, which is administered inside the body to produce active immunity to the same organism. Antibodies are built against the particular bacteria, that helps to prevent bacterial infection later. It can be produced in a variety of ways.
Bacterial Vaccines Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Live Attenuated Vaccines, Inactivated/Killed Vaccines, Subunit/Conjugate, Toxoid Vaccines/Inactivated Toxin, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Sanofi (France), Boehringer Ingelheim International GmbH. (Germany), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (U.S.), Bharat Biotech (India), Serum Institute of India Pvt. Ltd (India), EMERGENT (U.S.)
|
|
Market Opportunities
|
|
Global Bacterial Vaccines Market Dynamics
Drivers
- Rising Awareness
In the last few years, government and non-government organizations in developing countries, have taken extreme efforts to raise awareness for preventive medicine. Several programs are conducted that reach out to uneducated people especially in rural areas. This is a key factor that boosts the Bacterial Vaccines Market in the world's emerging economies.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increasing Demand for Retail Pharmacies
Opportunities for market expansion are created by the rise in the number of hepatitis e-therapeutics distributed through retail pharmacies and the rise in the number of retail pharmacies in developed nations. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
- Rising Prevalence of antibiotic-resistant infections
The increasing incidence of these infections create opportunities for market growth. As per the reports of 2019 AR Threats, more than 2.8 million antibiotic-resistant infections are prevalent in the U.S. each year, and more than 35,000 people die as a consequence. This boosts the market growth.
Restraints/Challenges
- Lack of skilled professionals
The lack of healthcare professionals who are unable to treat the patients with appropriate treatments could restrict the growth of the global bacterial vaccines market over a forecast period.
- Side Effects of Bacterial Vaccines
There are many side effects associated with bacterial vaccines that surely hamper the market growth. Side effects such as fever, chills, enduration, pain and soreness, and many such effects restrain the growth of the market.
This global bacterial vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global bacterial vaccines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Bacterial Vaccines Market Scope
The global bacterial vaccines market is segmented on the basis of type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Live Attenuated Vaccines
- Inactivated/Killed Vaccines
- Subunit/Conjugate
- Toxoid Vaccines/Inactivated Toxin
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Bacterial Vaccines Market Regional Analysis/Insights
The global bacterial vaccines market is analysed and market size insights and trends are provided by type, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global bacterial vaccines market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for global bacterial vaccines market throughout the forecasted period due to increased healthcare expenditure and government focus towards providing reliable healthcare solution.
Asia-Pacific dominates the market due to increased awareness towards poliomyelitis and rapidly improving health care infrastructure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Bacterial Vaccines Market Share Analysis
The global bacterial vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global bacterial vaccines market.
Key players operating in the global bacterial vaccines market include:
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Sanofi (France)
- Boehringer Ingelheim International GmbH. (Germany)
- Merck & Co., Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bristol-Myers Squibb Company (U.S.)
- Bharat Biotech (India)
- Serum Institute of India Pvt. Ltd (India)
- EMERGENT (U.S.)
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key
SKU-